Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | January 19, 2023 01:30pm

Gainers

  • BeyondSpring (NASDAQ:BYSI) stock moved upwards by 24.4% to $2.7 during Thursday's regular session. Trading volume for BeyondSpring's stock is 1.2 million as of 12:30 EST. This is 132.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $105.1 million.
  • Concert Pharma (NASDAQ:CNCE) shares rose 20.28% to $8.3. The current volume of 44.2 million shares is 9544.2% of Concert Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $397.8 million.
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares moved upwards by 17.93% to $1.25. Bellicum Pharmaceuticals's stock is trading at a volume of 294.3K shares as of 12:30 EST. This is 1178.7% of its average full-day volume over the last 100 days. The company's market cap stands at $10.7 million.
  • AnPac Bio-Medical Science (NASDAQ:ANPC) stock increased by 14.91% to $10.2. Trading volume for this security as of 12:30 EST is 150.1K, which is 374.8% of its average full-day volume over the last 100 days. The company's market cap stands at $416.2 million.
  • Apexigen (NASDAQ:APGN) shares increased by 13.19% to $2.03. Trading volume for Apexigen's stock is 7.3 million as of 12:30 EST. This is 416.0% of its average full-day volume over the last 100 days. The company's market cap stands at $45.7 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved upwards by 12.49% to $1.17. As of 12:30 EST, this security is trading at a volume of 5.8 million shares, making up 91.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $67.3 million.

Losers

  • Aceragen (NASDAQ:ACGN) shares declined by 32.9% to $5.8 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 155.6K shares, making up 13.8% of its average full-day volume over the last 100 days. The company's market cap stands at $21.2 million.
  • Surmodics (NASDAQ:SRDX) stock declined by 30.21% to $26.06. As of 12:30 EST, this security is trading at a volume of 307.2K shares, making up 709.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $368.1 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock fell 26.99% to $4.6. Trading volume for this security as of 12:30 EST is 1.2 million, which is 172.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $182.8 million.
  • Black Diamond Therapeutic (NASDAQ:BDTX) stock decreased by 23.77% to $2.39. As of 12:30 EST, this security is trading at a volume of 300.8K shares, making up 145.4% of its average full-day volume over the last 100 days. The company's market cap stands at $87.0 million.
  • GeneDx Holdings (NASDAQ:WGS) shares decreased by 20.76% to $0.36. Trading volume for this security as of 12:30 EST is 1.6 million, which is 84.3% of its average full-day volume over the last 100 days. The company's market cap stands at $138.5 million.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) stock fell 20.58% to $0.63. Trading volume for Hepion Pharmaceuticals's stock is 3.1 million as of 12:30 EST. This is 492.2% of its average full-day volume over the last 100 days. The company's market cap stands at $48.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACGN ANPC APGN BDTX BLCM BYSI CNCE HEPA SRDX TCBP TNXP WGS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist